Search

Author/Creator Murphy, Sabina A

1. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)

Authors:
Ruff, Christian T; Giugliano, Robert P; Braunwald, Eugene; Morrow, David A; Murphy, Sabina A; Kuder, Julia F; Deenadayalu, Naveen; Jarolim, Petr; Betcher, Joshua; Shi, Minggao; Brown, Karen; Patel, Indravadan; Mercuri, Michele; Antman, Elliott M
Journal:
Lancet
Issue:
Volume 385:Issue 9984(2015)
Page Start:
2288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Issue 12 (December 2017)

Authors:
Sabatine, Marc S; Leiter, Lawrence A; Wiviott, Stephen D; Giugliano, Robert P; Deedwania, Prakash; De Ferrari, Gaetano M; Murphy, Sabina A; Kuder, Julia F; Gouni-Berthold, Ioanna; Lewis, Basil S; Handelsman, Yehuda; Pineda, Armando Lira; Honarpour, Narimon; Keech, Anthony C; Sever, Peter S; Peder...
Journal:
Lancet
Issue:
Volume 5:Issue 12(2017)
Page Start:
941
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial. Issue 2 (19th November 2018)

Authors:
Steffel, Jan; Ruff, Christian T; Braunwald, Eugene; Hamershock, Rose A; Murphy, Sabina A; Nieminen, Markku; Lanz, Hans-Joachim; Mercuri, Michele F; Peterson, Nancy; Antman, Elliott M; Giugliano, Robert P
Journal:
Europace
Issue:
Volume 21:Issue 2(2019)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial. (19th September 2021)

Authors:
Oyama, Kazuma; Giugliano, Robert P; Tang, Minao; Bonaca, Marc P; Saver, Jeffrey L; Murphy, Sabina A; Ruzza, Andrea; Keech, Anthony C; Sever, Peter S; Sabatine, Marc S; Bergmark, Brian A
Journal:
European heart journal
Issue:
Volume 42:Number 47(2021)
Page Start:
4821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Issue 10161 (24th November 2018)

Authors:
Bohula, Erin A; Scirica, Benjamin M; Inzucchi, Silvio E; McGuire, Darren K; Keech, Anthony C; Smith, Steven R; Kanevsky, Estella; Murphy, Sabina A; Leiter, Lawrence A; Dwyer, Jamie P; Corbalan, Ramon; Hamm, Christian; Kaplan, Lee; Nicolau, Jose Carlos; Ophuis, Ton Oude; Ray, Kausik K; Ruda, Mikha...
Journal:
Lancet
Issue:
Volume 392:Issue 10161(2018)
Page Start:
2269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial. (April 2020)

Authors:
Qamar, Arman; Morrow, David A; Creager, Mark A; Scirica, Benjamin M; Olin, Jeffrey W; Beckman, Joshua A; Murphy, Sabina A; Bonaca, Marc P
Journal:
Vascular medicine
Issue:
Volume 25:Number 2(2020)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial. Issue 8 (August 2019)

Authors:
Mosenzon, Ofri; Wiviott, Stephen D; Cahn, Avivit; Rozenberg, Aliza; Yanuv, Ilan; Goodrich, Erica L; Murphy, Sabina A; Heerspink, Hiddo J L; Zelniker, Thomas A; Dwyer, Jamie P; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Kato, Eri T; Gause-Nilsson, Ingrid A M; Fredri...
Journal:
Lancet
Issue:
Volume 7:Issue 8(2019)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial. Issue 4 (April 2023)

Authors:
Schechter, Meir; Wiviott, Stephen D; Raz, Itamar; Goodrich, Erica L; Rozenberg, Aliza; Yanuv, Ilan; Murphy, Sabina A; Zelniker, Thomas A; Fredriksson, Martin; Johansson, Peter A; Leiter, Lawrence A; Bhatt, Deepak L; McGuire, Darren K; Wilding, John P H; Gause-Nilsson, Ingrid A M; Cahn, Avivit; La...
Journal:
Lancet
Issue:
Volume 11:Issue 4(2023)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗